|
How Is Cystic Fibrosis Treated?
Since CF is a genetic disease, the only way to prevent or cure
it would be with gene therapy at an early age. Ideally, gene therapy
could repair or replace the defective gene. Another option for treatment
would be to give a person with CF the active form of the protein
product that is scarce or missing. At present, neither gene therapy
nor any other kind of treatment exists for the basic causes of CF,
although several drug-based approaches are being investigated. In
the meantime, the best that doctors can do is to ease the symptoms
of CF or slow the progress of the disease so the patient's quality
of life is improved. This is achieved by antibiotic therapy combined
with treatments to clear the thick mucus from the lungs. The therapy
is tailored to the needs of each patient. For patients whose disease
is very advanced, lung transplantation may be an option. CF was
once always fatal in childhood. Better treatment methods developed
over the past 20 years have increased the average lifespan of CF
patients to nearly 30 years.
These treatment approaches are detailed more
fully below:
* Management of lung problems A major focus of CF treatment is
the obstructed breathing that causes frequent lung infections. Physical
therapy, exercise, and medications are used to reduce the mucus
blockage of the lung's airways. Chest therapy consists of bronchial,
or postural, drainage, which is done by placing the patient in a
position that allows drainage of the mucus from the lungs. At the
same time, the chest or back is clapped (percussed) and vibrated
to dislodge the mucus and help it move out of the airways. This
process is repeated over different parts of the chest and back to
loosen the mucus in different areas of each lung. This procedure
has to be done for children by family members but older patients
can learn to do it by themselves. Mechanical aids that help chest
physical therapy are available commercially. Exercise also helps
to loosen the mucus, stimulate coughing to clear the mucus, and
improve the patient's overall physical condition. Medications used
to help breathing are often aerosolized (misted) and can be inhaled.
These medicines include bronchodilators (which widen the breathing
tubes), mucolytics (which thin the mucus), and decongestants (which
reduce swelling of the membranes of the breathing tubes). A recent
advance, approved by the Food and Drug Administration, is an inhaled
aerosolized enzyme that thins the mucus by digesting the cellular
material trapped in it. Antibiotics to fight lung infections also
are used and may be taken orally or in aerosol form, or by injection
into a vein. * Management of digestive problems The digestive problems
in CF are less serious and more easily managed than those in the
lungs. A well-balanced, high-caloric diet, low in fat and high in
protein, and pancreatic enzymes (which help digestion) are often
prescribed. Supplements of vitamins A, D, E, and K are given to
ensure good nutrition. Enemas and mucolytic agents are used to treat
intestinal obstructions. ____________________________________________________________
Gene Therapy-The Future of CF Treatment?
Gene therapy for CF is not yet possible but impressive progress
is being made in developing ways to treat the gene abnormality that
causes CF. In the laboratory, scientists have been able to grow
cells from the nasal passages of CF patients. By introducing the
normal gene into these cells, researchers corrected the cells' chloride
transport abnormality. The chloride defect has also been corrected
in small regions in the nasal passages themselves by giving CF patients
the normal gene in nose drops. Scientists are still looking for
answers to many questions about gene therapy.
Some of these questions are: How should the gene be packaged? What
are the best ways to get the gene-containing package into the patient's
lungs? What will the long-term results of this treatment be? Can
the abnormal chloride transport be corrected in other parts of the
body? How long will the correction last? And, most importantly,
can gene therapy cure or prevent the lung disease in CF? Is It Possible
to Detect CF in an Unborn Baby?
Finding out whether a baby is likely to have CF is possible using
prenatal genetic tests. However, the tests cannot detect all of
the CF gene mutations. Also, because these tests are very expensive
and have certain risks to the mother, they are not used for all
pregnant women. If there is another child with CF in the family,
the expectant mother may request a prenatal test to see if the fetus
has CF genes from both parents, is a carrier for one gene, or is
altogether free of the CF genes.
There are two special prenatal tests that can be done-either an
amniocentesis or chorionic villus biopsy will be performed. In amniocentesis,
cells from the fluid surrounding the baby in the mother's womb (called
the amniotic fluid) are tested to see if the CF genes common to
the parents are present. In chorionic villus biopsy, cells from
the tissue that will eventually form the placenta are tested for
the CF gene. Can CF Be Prevented? At this time, preventing CF is
not possible. In babies with two abnormal CF genes, the disease
is already present at birth in some organs, such as the pancreas
and liver, but develops only after birth in the lungs. Someday,
gene therapy may be used to prevent the lung disease from developing.
Yet, CF might be prevented in the future. Since CF occurs only when
both parents pass on a CF gene to a child, it could be prevented
by identifying all carriers of CF genes. Genetic counselors might
then persuade couples who are carriers not to have children. However,
as noted, current tests can detect only some of the more than 400
gene mutations and so the tests are only 80-85 percent accurate.
Yet, progress in gene therapy and the realization that not all CF
mutations are life-threatening should reassure couples. Potential
parents who carry the defective gene may choose to have children.
How Can Patients and Their Families and Friends
Be Helped To Cope with CF?
CF education helps patients and their families face the physical
and emotional effects of the disease and encourages CF patients
to lead active, fulfilling lives. Educational programs and materials
suitable for both patients of various ages and their parents are
available from local CF centers and from local chapters of the CF
Foundation. Patients and their families and friends should know
that:
* CF parents should not feel guilty or responsible for causing
their child's disease; they could not have prevented it.
* Parents should treat their children with CF as normally as possible.
They shouldn't be over-protective but should encourage them to be
active and self-reliant.
* Family and friends should remember that CF is not contagious;
nobody can get it from a patient.
* In families with CF, brothers, sisters, and first cousins of
the CF patient should be tested to see if they carry a defective
gene, especially if they seem to have a chronic lung or digestive
problem. Carriers of the abnormal gene should get genetic counseling.
* Individuals with CF have normal sexual development and can expect
to have a normal sex life. However, most, but not all, men are infertile
because of a mechanical blockage of sperm and cannot have children.
Women with CF can have children, although they may be less fertile
than women without CF.
* Patients and families should work closely with doctors and other
medical specialists to develop self-management skills that can improve
their quality of life. Above all, CF patients and their families
should keep a positive attitude. Scientists continue to make significant
advances in understanding the genetic and physiological disturbances
in CF and in developing new treatment approaches such as gene therapy.
The outlook is bright for further improvements in the care of CF
patients and even for the discovery of a cure.
For More Information Additional information about CF can be obtained
from the following organizations: National Heart, Lung, and Blood
Institute (NHLBI) Information Center P.O. Box 30105 Bethesda, MD
20824-0105 Telephone: 301-592-8573 The Cystic Fibrosis Foundation
6931 Arlington Road, #200 Bethesda, MD 20814 Telephone: 301-951-4422
1-800-344-4823 National Diabetes Information Clearinghouse 1 Information
Way Bethesda, MD 20892-3560 Telephone: 301-654-3327 1-800-891-5388
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service
National Institutes of Health National Heart, Lung, and Blood Institute
NIH Publication No. 95-3650 November 1995 .
|